Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
10/2000
10/12/2000WO2000059509A1 Phthalazine derivatives for treating inflammatory diseases
10/12/2000WO2000059506A1 HETEROCYCLIC CONTAINING BIPHENYL aP2 INHIBITORS AND METHOD
10/12/2000WO2000059505A1 Inhibitors for vascular reconstriction after angioplasty
10/12/2000WO2000059504A1 Method for the treatment of neurological or neuropsychiatric disorders
10/12/2000WO2000059503A1 Pyrrolidine modulators of chemokine receptor activity
10/12/2000WO2000059502A1 Pyrrolidine modulators of chemokine receptor activity
10/12/2000WO2000059498A1 Pyrrolidine modulators of chemokine receptor activity
10/12/2000WO2000059497A1 Pyrrolidine modulators of chemokine receptor activity
10/12/2000WO2000059495A1 (e)-styryl sulfone anticancer agents
10/12/2000WO2000059484A2 Use of arylalkanoylpyridazines
10/12/2000WO2000059483A2 Transdermal drug delivery devices comprising a polyurethane drug reservoir
10/12/2000WO2000059448A2 Association of no-synthase inhibitor(s) and metabolic antioxidant(s)
10/12/2000WO2000035939A3 Connective tissue growth factor fragments and methods and uses thereof
10/12/2000WO2000018918A9 Genes and proteins predictive and therapeutic for stroke, hypertension, diabetes and obesity
10/12/2000WO1999064039A9 Bradykinin antagonists
10/12/2000WO1998025597A3 Method for treating and preventing heart failure and ventricular dilatation
10/12/2000WO1997036919A3 Cytokine designated lerk-8
10/12/2000WO1993012754A3 Tertiary and secondary amines as alpha-2 antagonists and serotonin uptake inhibitors
10/12/2000DE19915364A1 Verwendung von Arylalkanoylpyridazinen Use of Arylalkanoylpyridazinen
10/12/2000CA2373717A1 Pyrrolidine modulators of chemokine receptor activity
10/12/2000CA2369871A1 .alpha.-substituted carboxylic acid derivatives
10/12/2000CA2369544A1 Aryl and heteroaryl fused aminoalkyl-imidazole derivatives:selective modulators of bradykinin b2 receptors
10/12/2000CA2369446A1 Substituted azetidin-2-ones as cysteine protease inhibitors
10/12/2000CA2369071A1 Novel lipoic acid derivatives, their preparation, pharmaceutical use and pharmaceutical compositions cantaining them
10/12/2000CA2368686A1 Substituted 1,4-dihydroindeno[1,2-c]pyrazoles as inhibitors of tyrosine kinase
10/12/2000CA2368240A1 N-(2-phenyl-4-amino-butyl)-1-naphthamides as neurokinin-1 receptor antagonists
10/12/2000CA2368183A1 Supar stimulating activity of tcupa-mediated fibrinolysis and different uses thereof
10/12/2000CA2368017A1 Use of erbb receptor ligands in treating diabetes
10/12/2000CA2367378A1 Molecules of the immune system
10/12/2000CA2367100A1 Transdermal drug delivery devices comprising a polyurethane drug reservoir
10/12/2000CA2367051A1 Use of arylalkanoylpyridazines
10/12/2000CA2366944A1 Pyrrolidine modulators of chemokine receptor activity
10/12/2000CA2366858A1 Sorbitol dehydrogenase inhibitors
10/12/2000CA2366850A1 Method for the treatment of neurological or neuropsychiatric disorders
10/12/2000CA2366264A1 Novel amide derivatives as inhibitors of matrix metalloproteinases, tnf-.alpha., and aggrecanase
10/12/2000CA2365834A1 Herbal compositions and uses for the treatment of allergic reactions
10/12/2000CA2365578A1 Thienopyrimidine compounds and salts thereof and process for the preparation of the same
10/12/2000CA2365500A1 Association of no-synthase inhibitor(s) and metabolic antioxidant(s)
10/12/2000CA2365421A1 Vesicle associated proteins
10/12/2000CA2365419A1 Novel thiazolobenzoimidazole derivatives
10/12/2000CA2365040A1 Hob-bp2h compositions, methods and uses thereof
10/12/2000CA2361988A1 Use of tianeptin in the production of medicaments to treat neurodegenerative pathologies
10/11/2000EP1043333A1 NOVEL POLYPEPTIDES, cDNAS ENCODING THE SAME AND UTILIZATION THEREOF
10/11/2000EP1043307A2 3-amino-3-arylpropan-1-ol-derivates, their preparation and their use
10/11/2000EP1043306A2 3-amino-3-arylpropan-1-ol-derivates, their preparation and use
10/11/2000EP1042674A1 148 human secreted proteins
10/11/2000EP1042498A1 A method of finding agonist and antagonist to human 11cb splice variant
10/11/2000EP1042468A2 Low-voltage activated calcium channel compositions and methods
10/11/2000EP1042460A1 Brain or heart cyclic nucleotide gated ion channel compounds and uses thereof
10/11/2000EP1042368A1 Antibodies against phosphorylated vasp (vasodilator-stimulated phosphoprotein), hybridoma cells for their preparation, and their use
10/11/2000EP1042365A1 Compounds and methods for modulating occludin related tissue permeability
10/11/2000EP1042348A1 Platelet derived growth factor (pdgf) nucleic acid ligand complexes
10/11/2000EP1042343A1 Vegi, an inhibitor of angiogenesis and tumor growth
10/11/2000EP1042316A1 Indole derivatives useful a.o. for the treatment of osteoporosis
10/11/2000EP1042307A1 Aminothiazole inhibitors of cyclin dependent kinases
10/11/2000EP1042297A1 Carboxyl acid substituted heterocycles as metalloproteinase inhibitors
10/11/2000EP1042296A1 Substituted isoquinoline derivatives and their use as anticonvulsants
10/11/2000EP1042290A1 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
10/11/2000EP1042287A1 Indole derivatives as inhibitors of factor xa
10/11/2000EP1042279A1 Substituted beta-alanines
10/11/2000EP1042278A1 1,3-disubstituted ureas as acat inhibitors, and method of preparing thereof
10/11/2000EP1042276A1 Thiourea and benzamide compounds, compositions and methods of treating or preventing inflammatory diseases and atherosclerosis
10/11/2000EP1042003A1 Delivery of long lasting therapeutic agents by forming covalent attachments in vivo
10/11/2000EP1041992A1 Hyperhydrated citicoline, process and use
10/11/2000EP1041991A1 Method for inhibiting cyclooxygenase-2 and tumor necrosis factor alpha
10/11/2000EP1041986A1 Pharmaceutically active compound and methods of use
10/11/2000EP1041982A1 INHIBITION OF p38 KINASE ACTIVITY USING SUBSTITUTED HETEROCYCLIC UREAS
10/11/2000EP1041980A1 Acyl guanidine sodium/proton exchange inhibitors and method
10/11/2000EP1041882A1 Transvascular delivery of a composition to an extravascular tissue of a mammal
10/11/2000EP0832075B1 n-(2,4-dioxo-2,3,4,5-tetrahydro-1h-1,5-benzodiazepin-3y l)-3-amides
10/11/2000CN1269800A Tetrahydro Gamma-carbolines
10/11/2000CN1269792A Novel carboxylic acid derivatives, their preparation and use as mixed ETA/ETB endothelin-receptor atagonists
10/11/2000CN1269790A Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocine-10-oles, method for production and use thereof as medicaments
10/11/2000CN1269722A Method and composition for modulating responsiveness to corticosteroids
10/11/2000CN1269715A Method and composition for treating late allergic reactions and inflammation diseases
10/11/2000CN1269240A Medicated Yindanjuming tea
10/11/2000CN1057296C Morpholine and thiomorpholine tachykinin receptor antagonists and use
10/11/2000CN1057295C Sulfonamide endothelin antagonists and use thereof
10/11/2000CN1057292C Dicyclic compound, medicinal composition containing same and use thereof
10/11/2000CN1057230C Chinese medicine capsule for treating thrombophlebitis
10/11/2000CN1057223C Method for preparing medicine liquor with heart and brain recovery function
10/11/2000CN1057221C Chinese medicine capsule for treating apolexy
10/11/2000CN1057217C Seabuckthorn fruit yolk health oil and its producing method
10/10/2000US6130240 Compound for treatment of cardiac arrhythmia, synthesis, and methods of use
10/10/2000US6130231 Integrin receptor antagonists
10/10/2000US6130223 Thienopyrimidine with phosphodiesterase V inhibiting effect
10/10/2000US6130218 High blood pressure
10/10/2000US6130208 Formulation containing a nucleotide analogue
10/10/2000US6130071 Vascular endothelial growth factor C (VEGF-C) ΔCys156 protein and gene, and uses thereof
10/10/2000US6129918 Method and pharmaceutical composition for reducing serum homocysteine concentration
10/10/2000CA2030516C Parathyroid hypertensive factor
10/07/2000CA2304127A1 3-amino-3-arylpropan-1-ol derivatives, and their preparation and use
10/07/2000CA2303721A1 3-amino-3-arylpropan-1-ol derivatives, their preparation and use
10/06/2000CA2267929A1 Preparation of saturated phytosterols
10/05/2000WO2000058513A1 49 human secreted proteins
10/05/2000WO2000058496A1 50 human secreted proteins
10/05/2000WO2000058495A1 45 human secreted proteins
10/05/2000WO2000058494A1 50 human secreted proteins
10/05/2000WO2000058473A2 Nucleic acids including open reading frames encoding polypeptides; 'orfx'
10/05/2000WO2000058468A2 47 human secreted proteins
1 ... 1259 1260 1261 1262 1263 1264 1265 1266 1267 1268 1269 1270 1271 1272 1273 1274 1275 1276 1277 1278 1279 ... 1595